<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">31859216</PMID><DateCompleted><Year>2020</Year><Month>06</Month><Day>25</Day></DateCompleted><DateRevised><Year>2024</Year><Month>07</Month><Day>30</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1474-4457</ISSN><JournalIssue CitedMedium="Internet"><Volume>20</Volume><Issue>2</Issue><PubDate><Year>2020</Year><Month>Feb</Month></PubDate></JournalIssue><Title>The Lancet. Infectious diseases</Title><ISOAbbreviation>Lancet Infect Dis</ISOAbbreviation></Journal><ArticleTitle>Clinical characteristics of enterovirus A71 neurological disease during an outbreak in children in Colorado, USA, in 2018: an observational cohort study.</ArticleTitle><Pagination><StartPage>230</StartPage><EndPage>239</EndPage><MedlinePgn>230-239</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/S1473-3099(19)30632-2</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S1473-3099(19)30632-2</ELocationID><Abstract><AbstractText Label="BACKGROUND">In May, 2018, Children's Hospital Colorado noted an outbreak of enterovirus A71 (EV-A71) neurological disease. We aimed to characterise the clinical features of EV-A71 neurological disease during this outbreak.</AbstractText><AbstractText Label="METHODS">In this retrospective observational cohort study, children (younger than 18 years) who presented to Children's Hospital Colorado (Aurora, CO, USA) between March 1 and November 30, 2018, with neurological disease (defined by non-mutually exclusive criteria, including meningitis, encephalitis, acute flaccid myelitis, and seizures) and enterovirus detected from any biological specimen were eligible for study inclusion. The clinical characteristics of children with neurological disease associated with EV-A71 were compared with those of children with neurological disease associated with other enteroviruses during the same period. To explore the differences in clinical presentation of acute flaccid myelitis, we also used a subgroup analysis to compare clinical findings in children with EV-A71-associated acute flaccid myelitis during the study period with these findings in those with enterovirus D68 (EV-D68)-associated acute flaccid myelitis at the same hospital between 2013 and 2018.</AbstractText><AbstractText Label="FINDINGS">Between March 10 and Nov 10, 2018, 74 children presenting to Children's Hospital Colorado were found to have enterovirus neurological disease; EV-A71 was identified in 43 (58%) of these children. The median age of the children with EV-A71 neurological disease was 22&#xb7;7 months (IQR 4&#xb7;0-31&#xb7;9), and most of these children were male (34 [79%] children). 40 (93%) children with EV-A71 neurological disease had findings suggestive of meningitis, 31 (72%) children showed evidence of encephalitis, and ten (23%) children met our case definition of acute flaccid myelitis. All children with EV-A71 disease had fever and 18 (42%) children had hand, foot, or mouth lesions at or before neurological onset. Children with EV-A71 disease were best differentiated from those with other enteroviruses (n=31) by the neurological findings of myoclonus, ataxia, weakness, and autonomic instability. Of the specimens collected from children with EV-A71, this enterovirus was detected in 94% of rectal, 79% of oropharyngeal, 56% of nasopharyngeal, and 20% of cerebrospinal fluid specimens. 39 (93%) of 42 children with EV-A71 neurological disease who could be followed up showed complete recovery by 1-2 months. Compared with children with EV-D68-associated acute flaccid myelitis, children with EV-A71-associated acute flaccid myelitis were younger, showed neurological onset earlier after prodromal symptom onset, had milder weakness, showed more rapid improvement, and were more likely to completely recover.</AbstractText><AbstractText Label="INTERPRETATION">This outbreak of EV-A71 neurological disease, the largest reported in the Americas, was characterised by fever, myoclonus, ataxia, weakness, autonomic instability, and full recovery in most patients. Because EV-A71 epidemiology outside of Asia remains difficult to predict, identification of future outbreaks will be aided by prompt recognition of these distinct clinical findings, testing of non-sterile and sterile site specimens, and enhanced enterovirus surveillance.</AbstractText><AbstractText Label="FUNDING">None.</AbstractText><CopyrightInformation>Copyright &#xa9; 2020 Elsevier Ltd. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Messacar</LastName><ForeName>Kevin</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Section of Infectious Diseases, School of Medicine, University of Colorado, Aurora, CO, USA; Children's Hospital Colorado, Aurora, CO, USA. Electronic address: kevin.messacar@childrenscolorado.org.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Spence-Davizon</LastName><ForeName>Emily</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Colorado Department of Public Health and the Environment, Denver, CO, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Osborne</LastName><ForeName>Christina</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Section of Infectious Diseases, School of Medicine, University of Colorado, Aurora, CO, USA; Children's Hospital Colorado, Aurora, CO, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Press</LastName><ForeName>Craig</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Section of Child Neurology, School of Medicine, University of Colorado, Aurora, CO, USA; Children's Hospital Colorado, Aurora, CO, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Schreiner</LastName><ForeName>Teri L</ForeName><Initials>TL</Initials><AffiliationInfo><Affiliation>Section of Child Neurology, School of Medicine, University of Colorado, Aurora, CO, USA; Children's Hospital Colorado, Aurora, CO, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Martin</LastName><ForeName>Jan</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Section of Child Neurology, School of Medicine, University of Colorado, Aurora, CO, USA; Children's Hospital Colorado, Aurora, CO, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Messer</LastName><ForeName>Ricka</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Section of Child Neurology, School of Medicine, University of Colorado, Aurora, CO, USA; Children's Hospital Colorado, Aurora, CO, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Maloney</LastName><ForeName>John</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Section of Radiology, School of Medicine, University of Colorado, Aurora, CO, USA; Children's Hospital Colorado, Aurora, CO, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Burakoff</LastName><ForeName>Alexis</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Colorado Department of Public Health and the Environment, Denver, CO, USA; Centers for Disease Control and Prevention, Atlanta, GA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Barnes</LastName><ForeName>Meghan</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Colorado Department of Public Health and the Environment, Denver, CO, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rogers</LastName><ForeName>Shannon</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Centers for Disease Control and Prevention, Atlanta, GA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lopez</LastName><ForeName>Adriana S</ForeName><Initials>AS</Initials><AffiliationInfo><Affiliation>Centers for Disease Control and Prevention, Atlanta, GA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Routh</LastName><ForeName>Janell</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Centers for Disease Control and Prevention, Atlanta, GA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gerber</LastName><ForeName>Susan I</ForeName><Initials>SI</Initials><AffiliationInfo><Affiliation>Centers for Disease Control and Prevention, Atlanta, GA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Oberste</LastName><ForeName>M Steven</ForeName><Initials>MS</Initials><AffiliationInfo><Affiliation>Centers for Disease Control and Prevention, Atlanta, GA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nix</LastName><ForeName>W Allan</ForeName><Initials>WA</Initials><AffiliationInfo><Affiliation>Centers for Disease Control and Prevention, Atlanta, GA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Abzug</LastName><ForeName>Mark J</ForeName><Initials>MJ</Initials><AffiliationInfo><Affiliation>Section of Infectious Diseases, School of Medicine, University of Colorado, Aurora, CO, USA; Children's Hospital Colorado, Aurora, CO, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tyler</LastName><ForeName>Kenneth L</ForeName><Initials>KL</Initials><AffiliationInfo><Affiliation>Department of Pediatrics and Department of Neurology, School of Medicine, University of Colorado, Aurora, CO, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Herlihy</LastName><ForeName>Rachel</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Colorado Department of Public Health and the Environment, Denver, CO, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dominguez</LastName><ForeName>Samuel R</ForeName><Initials>SR</Initials><AffiliationInfo><Affiliation>Section of Infectious Diseases, School of Medicine, University of Colorado, Aurora, CO, USA; Children's Hospital Colorado, Aurora, CO, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>CC999999</GrantID><Acronym>ImCDC</Acronym><Agency>Intramural CDC HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D064888">Observational Study</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2019</Year><Month>12</Month><Day>16</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Lancet Infect Dis</MedlineTA><NlmUniqueID>101130150</NlmUniqueID><ISSNLinking>1473-3099</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentIn"><RefSource>Lancet Infect Dis. 2020 Feb;20(2):153-155. doi: 10.1016/S1473-3099(19)30679-6</RefSource><PMID Version="1">31859215</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D002675" MajorTopicYN="N">Child, Preschool</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003120" MajorTopicYN="N" Type="Geographic">Colorado</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004196" MajorTopicYN="N">Disease Outbreaks</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004770" MajorTopicYN="N">Enterovirus</DescriptorName><QualifierName UI="Q000302" MajorTopicYN="Y">isolation &amp; purification</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004769" MajorTopicYN="N">Enterovirus Infections</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007223" MajorTopicYN="N">Infant</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009422" MajorTopicYN="N">Nervous System Diseases</DescriptorName><QualifierName UI="Q000821" MajorTopicYN="Y">virology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement>Declaration of interests. KM reports a grant from the US National Institutes of Health and the National Institute of Allergy and Infectious Diseases, during the conduct of the study. ES-D reports grants from the US Centers for Disease Control and Prevention (CDC) during the conduct of the study. MSO and WAN hold a patent for nucleic acid molecules and kits (including VP1 and VP3) for detecting and identifying enteroviruses (US patent number 7,714,122) and a patent for detecting and identifying enteroviruses by semi-nested amplification of enterovirus VP1 protein (number 7,247,457). RH reports grants from the CDC during the conduct of the study. SRD reports grants from BioFire Diagnostics and from Pfizer, and personal fees from BioFire Diagnostics, outside the submitted work. All other authors declare no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2019</Year><Month>7</Month><Day>30</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2019</Year><Month>10</Month><Day>15</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2019</Year><Month>10</Month><Day>22</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2019</Year><Month>12</Month><Day>21</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>6</Month><Day>26</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2019</Year><Month>12</Month><Day>21</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>7</Month><Day>29</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">31859216</ArticleId><ArticleId IdType="mid">NIHMS2009845</ArticleId><ArticleId IdType="pmc">PMC11284833</ArticleId><ArticleId IdType="doi">10.1016/S1473-3099(19)30632-2</ArticleId><ArticleId IdType="pii">S1473-3099(19)30632-2</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Ooi MH, Wong SC, Lewthwaite P, Cardosa MJ, Solomon T. Clinical features, diagnosis, and management of enterovirus 71. Lancet Neurol 2010; 9: 1097&#x2013;105.</Citation><ArticleIdList><ArticleId IdType="pubmed">20965438</ArticleId></ArticleIdList></Reference><Reference><Citation>Solomon T, Lewthwaite P, Perera D, Cardosa MJ, McMinn P, Ooi MH. Virology, epidemiology, pathogenesis, and control of enterovirus 71. Lancet Infect Dis 2010; 10: 778&#x2013;90.</Citation><ArticleIdList><ArticleId IdType="pubmed">20961813</ArticleId></ArticleIdList></Reference><Reference><Citation>Teoh HL, Mohammad SS, Britton PN, et al. Clinical characteristics and functional motor outcomes of enterovirus 71 neurological disease in children. JAMA Neurol 2016; 73: 300&#x2013;07.</Citation><ArticleIdList><ArticleId IdType="pubmed">26785318</ArticleId></ArticleIdList></Reference><Reference><Citation>Casas-Alba D, de Sevilla MF, Valero-Rello A, et al. Outbreak of brainstem encephalitis associated with enterovirus-A71 in Catalonia, Spain (2016): a clinical observational study in a children&#x2019;s reference centre in Catalonia. Clin Microbiol Infect 2017; 23: 874&#x2013;81.</Citation><ArticleIdList><ArticleId IdType="pubmed">28344164</ArticleId></ArticleIdList></Reference><Reference><Citation>Ngangas ST, Lukashev A, Jugie G, et al. Multirecombinant enterovirus A71 subgenogroup C1 Isolates associated with neurologic disease, France, 2016&#x2013;2017. Emerg Infect Dis 2019; 25: 1204&#x2013;08.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6537711</ArticleId><ArticleId IdType="pubmed">31107209</ArticleId></ArticleIdList></Reference><Reference><Citation>B&#xf6;ttcher S, Diedrich S, Keeren K. Increased detection of enterovirus A71 infections, Germany, 2019. Euro Surveill 2019; 24: 1900556.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6774229</ArticleId><ArticleId IdType="pubmed">31576805</ArticleId></ArticleIdList></Reference><Reference><Citation>P&#xe9;rez-V&#xe9;lez CM, Anderson MS, Robinson CC, et al. Outbreak of neurologic enterovirus type 71 disease: a diagnostic challenge. Clin Infect Dis 2007; 45: 950&#x2013;57.</Citation><ArticleIdList><ArticleId IdType="pubmed">17879907</ArticleId></ArticleIdList></Reference><Reference><Citation>Khetsuriani N, Lamonte-Fowlkes A, Oberst S, Pallansch MA. Enterovirus surveillance&#x2014;United States, 1970&#x2013;2005. MMWR Surveill Summ 2006; 55: 1&#x2013;20.</Citation><ArticleIdList><ArticleId IdType="pubmed">16971890</ArticleId></ArticleIdList></Reference><Reference><Citation>Abedi GR, Watson JT, Pham H, Nix WA, Oberste MS, Gerber SI. Enterovirus and human parechovirus surveillance&#x2014;United States, 2009&#x2013;2013. MMWR Morb Mortal Wkly Rep 2015; 64: 940&#x2013;43.</Citation><ArticleIdList><ArticleId IdType="pubmed">26334674</ArticleId></ArticleIdList></Reference><Reference><Citation>Abedi GR, Watson JT, Nix WA, Oberste MS, Gerber SI. Enterovirus and parechovirus surveillance&#x2014;United States, 2014&#x2013;2016. MMWR Morb Mortal Wkly Rep 2018; 67: 515&#x2013;18.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5944979</ArticleId><ArticleId IdType="pubmed">29746455</ArticleId></ArticleIdList></Reference><Reference><Citation>Council of State and Territorial Epidemiologists. Standardized case definition for acute flaccid myelitis. 2015. http://c.ymcdn.com/sites/www.cste.org/resource/resmgr/2015PS/2015PSFinal/15-ID-01.pdf (accessed Oct 30, 2015).</Citation></Reference><Reference><Citation>Messacar K, Sillau S, Hopkins SE, et al. Safety, tolerability, and efficacy of fluoxetine as an antiviral for acute flaccid myelitis. Neurology 2019; 92: e2118&#x2013;26.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6512883</ArticleId><ArticleId IdType="pubmed">30413631</ArticleId></ArticleIdList></Reference><Reference><Citation>Kost CB, Rogers B, Oberste MS, et al. Multicenter beta trial of the GeneXpert enterovirus assay. J Clin Microbiol 2007; 45: 1081&#x2013;86.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1865814</ArticleId><ArticleId IdType="pubmed">17251395</ArticleId></ArticleIdList></Reference><Reference><Citation>Leber AL, Everhart K, Balada-Llasat JM, et al. Multicenter evaluation of BioFire FilmArray meningitis/encephalitis panel for detection of bacteria, viruses, and yeast in cerebrospinal fluid specimens. J Clin Microbiol 2016; 54: 2251&#x2013;61.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5005480</ArticleId><ArticleId IdType="pubmed">27335149</ArticleId></ArticleIdList></Reference><Reference><Citation>Poritz MA, Blaschke AJ, Byington CL, et al. FilmArray, an automated nested multiplex PCR system for multi-pathogen detection: development and application to respiratory tract infection. PLoS One 2011; 6: e26047.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3198457</ArticleId><ArticleId IdType="pubmed">22039434</ArticleId></ArticleIdList></Reference><Reference><Citation>Nix WA, Oberste MS, Pallansch MA. Sensitive, seminested PCR amplification of VP1 sequences for direct identification of all enterovirus serotypes from original clinical specimens. J Clin Microbiol 2006; 44: 2698&#x2013;704.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1594621</ArticleId><ArticleId IdType="pubmed">16891480</ArticleId></ArticleIdList></Reference><Reference><Citation>Li J, Chen F, Liu T, Wang L. MRI findings of neurological complications in hand-foot-mouth disease by enterovirus 71 infection. Int J Neurosci 2012; 122: 338&#x2013;44.</Citation><ArticleIdList><ArticleId IdType="pubmed">22248036</ArticleId></ArticleIdList></Reference><Reference><Citation>Chung PW, Huang YC, Chang LY, Lin TY, Ning HC. Duration of enterovirus shedding in stool. J Microbiol Immunol Infect 2001; 34: 167&#x2013;70.</Citation><ArticleIdList><ArticleId IdType="pubmed">11605806</ArticleId></ArticleIdList></Reference><Reference><Citation>Harvala H, Broberg E, Benschop K, et al. Recommendations for enterovirus diagnostics and characterisation within and beyond Europe. J Clin Virol 2018; 101: 11&#x2013;17.</Citation><ArticleIdList><ArticleId IdType="pubmed">29414181</ArticleId></ArticleIdList></Reference><Reference><Citation>Messacar K, Dominguez SR. Blood PCR testing for enteroviruses in young children. Lancet Infect Dis 2018; 18: 1299&#x2013;301.</Citation><ArticleIdList><ArticleId IdType="pubmed">30389483</ArticleId></ArticleIdList></Reference><Reference><Citation>Schubert RD, Hawes I, Ramachandran PS, et al. Pan-viral serology implicates enteroviruses in acute flaccid myelitis. Nat Med 2019; 25: 1748&#x2013;52.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6858576</ArticleId><ArticleId IdType="pubmed">31636453</ArticleId></ArticleIdList></Reference><Reference><Citation>Hu Y, Jiang L, Peng HL. Clinical analysis of 134 children with nervous system damage caused by enterovirus 71 infection. Pediatr Infect Dis J 2015; 34: 718&#x2013;23.</Citation><ArticleIdList><ArticleId IdType="pubmed">25860536</ArticleId></ArticleIdList></Reference><Reference><Citation>Chang LY, Huang LM, Gau SS, et al. Neurodevelopment and cognition in children after enterovirus 71 infection. N Engl J Med 2007; 356: 1226&#x2013;34.</Citation><ArticleIdList><ArticleId IdType="pubmed">17377160</ArticleId></ArticleIdList></Reference><Reference><Citation>Chang LY, Chang IS, Chen WJ, et al. HLA-A33 is associated with susceptibility to enterovirus 71 infection. Pediatrics 2008; 122: 1271&#x2013;76.</Citation><ArticleIdList><ArticleId IdType="pubmed">19047245</ArticleId></ArticleIdList></Reference><Reference><Citation>Yen TY, Shih WL, Huang YC, Lee JT, Huang LM, Chang LY. Polymorphisms in enterovirus 71 receptors associated with susceptibility and clinical severity. PLoS One 2018; 13: e0206769.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6218064</ArticleId><ArticleId IdType="pubmed">30395634</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang B, Wu X, Huang K, et al. The variations of VP1 protein might be associated with nervous system symptoms caused by enterovirus 71 infection. BMC Infect Dis 2014; 14: 243.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4101859</ArticleId><ArticleId IdType="pubmed">24886383</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Q, MacDonald NE, Smith JC, et al. Severe enterovirus type 71 nervous system infections in children in the Shanghai region of China: clinical manifestations and implications for prevention and care. Pediatr Infect Dis J 2014; 33: 482&#x2013;87.</Citation><ArticleIdList><ArticleId IdType="pubmed">24732390</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang G, Wang J, Yao G, Shi B. Efficacy of high-dose methylprednisolone pulse therapy in the treatment of enterovirus 71 encephalitis. Pak J Pharm Sci 2016; 29 (suppl): 1421&#x2013;27.</Citation><ArticleIdList><ArticleId IdType="pubmed">27592493</ArticleId></ArticleIdList></Reference><Reference><Citation>Messacar K, Asturias EJ, Hixon AM, et al. Enterovirus D68 and acute flaccid myelitis&#x2014;evaluating the evidence for causality. Lancet Infect Dis 2018; 18: e239&#x2013;47.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6778404</ArticleId><ArticleId IdType="pubmed">29482893</ArticleId></ArticleIdList></Reference><Reference><Citation>Maloney JA, Mirsky DM, Messacar K, Dominguez SR, Schreiner T, Stence NV. MRI findings in children with acute flaccid paralysis and cranial nerve dysfunction occurring during the 2014 enterovirus D68 outbreak. AJNR Am J Neuroradiol 2015; 36: 245&#x2013;50.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7965662</ArticleId><ArticleId IdType="pubmed">25414005</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee HF, Chi CS. Enterovirus 71 infection-associated acute flaccid paralysis: a case series of long-term neurologic follow-up. J Child Neurol 2014; 29: 1283&#x2013;90.</Citation><ArticleIdList><ArticleId IdType="pubmed">24453152</ArticleId></ArticleIdList></Reference><Reference><Citation>Martin JA, Messacar K, Yang ML, et al. Outcomes of Colorado children with acute flaccid myelitis at 1 year. Neurology 2017; 89: 129&#x2013;37.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5501931</ArticleId><ArticleId IdType="pubmed">28615421</ArticleId></ArticleIdList></Reference><Reference><Citation>Chong P, Liu CC, Chow YH, Chou AH, Klein M. Review of enterovirus 71 vaccines. Clin Infect Dis 2015; 60: 797&#x2013;803.</Citation><ArticleIdList><ArticleId IdType="pubmed">25352588</ArticleId></ArticleIdList></Reference><Reference><Citation>Pons-Salort M, Grassly NC. Serotype-specific immunity explains the incidence of diseases caused by human enteroviruses. Science 2018; 361: 800&#x2013;03.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6559928</ArticleId><ArticleId IdType="pubmed">30139872</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>